Jane Street
ACTU

Jane Street’s Actuate Therapeutics ACTU Stock Holding History

Jane Street’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.9K Buy
+39,132
New +$90.7K ﹤0.01% 10856
2026
Q1 		– Sell
-16,625
Closed -$102K – 13288
2025
Q4 		$102K Buy
+16,625
New +$114K ﹤0.01% 10182

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $159M AUM 34.17% 1-Year Est. Return

Jane Street's ACTU Position: Q2 2026 in Review

Jane Street opened a new position in Actuate Therapeutics (ACTU) in Q2 2026: 39,132 shares worth $59.9K. The stake represents ﹤0.01% of the portfolio and ranks #10856 among its holdings. This is a return to the name: Jane Street previously reported a position in ACTU as recently as Q4 2025.

Jane Street first reported a position in ACTU in Q4 2025 and has held it in 2 quarters since. The position peaked at $102K in Q4 2025. 64 funds tracked by Wall St. Rank hold ACTU as of Q2 2026.

  • Jane Street held 39,132 shares of Actuate Therapeutics worth $59.9K as of Q2 2026.
  • Actuate Therapeutics was a new Jane Street position in Q2 2026.
  • Actuate Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10856 holding.
  • Jane Street first reported a position in Actuate Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Jane Street's Actuate Therapeutics position peaked at $102K in Q4 2025.
  • 64 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.